Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07474077
PHASE3

Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH

Sponsor: Sultan Qaboos University

View on ClinicalTrials.gov

Summary

Investigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.

Official title: PROPHYLACTIC TRANEXAMIC ACID IN REDUCING POSTPARTUM HEMORRHAGE IN CESAREAN SECTIONS

Key Details

Gender

FEMALE

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

88

Start Date

2026-05-01

Completion Date

2028-03-31

Last Updated

2026-04-01

Healthy Volunteers

Yes

Interventions

DRUG

tranexamic acid (1 g diluted in 100 mL of 0.9% saline

This intervention is currently used for treatment of postpartum hemorrhage and not a routine prophylaxis

DRUG

Normal (0.9%) saline

Intravenous volume matched normal 0.9% saline